Hani Kushlaf, MD

Claeys, Kristl G; Kushlaf, Hani; Raza, Syed; Hummel, Noemi; Shohet, Simon; Keyzor, Ian; Kopiec, Agnieszka; Graham, Ryan; Fox, Brian; Schoser, Benedikt 2024. Minimal clinically important differences in six-minute walking distance in late-onset Pompe disease. Orphanet journal of rare diseases, 19 1, 154

Day, Jessica; Kushlaf, Hani; Tarvin, Stacey; Cavagna, Lorenzo; Codullo, Veronica; Shinjo, Samuel Katsuyuki; Lyu, Xia; Knitza, Johannes; Hajji, Raouf; Blier, Peter R; Tseng, Chih Wei; Appenzeller, Simone; Rider, Lisa G; Christopher-Stine, Lisa; Gupta, Latika 2024. Telemedicine for the Care of Patients with Idiopathic Inflammatory Myopathies: Experience, Insights and Future Directions from the International Myositis Assessment and Clinical Studies Telemedicine Scientific Interest Group. Current rheumatology reports, ,

Howard, James F; Vu, Tuan; Mantegazza, Renato; Kushlaf, Hani; Suzuki, Shigeaki; Wiendl, Heinz; Beasley, Kathleen N; Liao, Serena; Meisel, Andreas 2024. Efficacy of ravulizumab in patients with generalized myasthenia gravis by time from diagnosis: A post hoc subgroup analysis of the CHAMPION MG study. Muscle & nerve, ,

Kishnani, Priya S; Byrne, Barry J; Claeys, Kristl G; Díaz-Manera, Jordi; Dimachkie, Mazen M; Kushlaf, Hani; Mozaffar, Tahseen; Roberts, Mark; Schoser, Benedikt; Hummel, Noemi; Kopiec, Agnieszka; Holdbrook, Fred; Shohet, Simon; Toscano, Antonio 2024. Switching treatment to cipaglucosidase alfa plus miglustat positively affects patient-reported outcome measures in patients with late-onset Pompe disease. Journal of patient-reported outcomes, 8 1, 132

Schoser, Benedikt; Kishnani, Priya S; Bratkovic, Drago; Byrne, Barry J; Claeys, Kristl G; Díaz-Manera, Jordi; Laforêt, Pascal; Roberts, Mark; Toscano, Antonio; van der Ploeg, Ans T; Castelli, Jeff; Goldman, Mitchell; Holdbrook, Fred; Sitaraman Das, Sheela; Wasfi, Yasmine; Mozaffar, Tahseen 2024. 104-week efficacy and safety of cipaglucosidase alfa plus miglustat in adults with late-onset Pompe disease: a phase III open-label extension study (ATB200-07). Journal of neurology, ,

Kishnani, Priya S; Diaz-Manera, Jordi; Toscano, Antonio; Clemens, Paula R; Ladha, Shafeeq; Berger, Kenneth I; Kushlaf, Hani; Straub, Volker; Carvalho, Gerson; Mozaffar, Tahseen; Roberts, Mark; Attarian, Shahram; Chien, Yin-Hsiu; Choi, Young-Chul; Day, John W; Erdem-Ozdamar, Sevim; Illarioshkin, Sergey; Goker-Alpan, Ozlem; Kostera-Pruszczyk, Anna; van der Ploeg, Ans T; An Haack, Kristina; Huynh-Ba, Olivier; Tammireddy, Swathi; Thibault, Nathan; Zhou, Tianyue; Dimachkie, Mazen M; Schoser, Benedikt 2023. Efficacy and Safety of Avalglucosidase Alfa in Patients With Late-Onset Pompe Disease After 97 Weeks: A Phase 3 Randomized Clinical Trial. JAMA neurology, 80 6, 558-567

Quintana, Melanie; Saville, Benjamin R; Vestrucci, Matteo; Detry, Michelle A; Chibnik, Lori; Shefner, Jeremy; Berry, James D; Chase, Marianne; Andrews, Jinsy; Sherman, Alexander V; Yu, Hong; Drake, Kristin; Cudkowicz, Merit; Paganoni, Sabrina; Macklin, Eric A 2023. Design and Statistical Innovations in a Platform Trial for Amyotrophic Lateral Sclerosis. Annals of neurology, 94 3, 547-560

Roy, Bhaskar; Lucchini, Matteo; Lilleker, James B; Goyal, Namita A; Naddaf, Elie; Adler, Brittany; Alfano, Lindsay N; Malandraki, Georgia A; Focht Garand, Kendrea L; Mochel, David; Badrising, Umesh; Machado, Pedro M; Pagkatipunan, Ruben; Ramdharry, Gita; Wang, Leo; Funaro, Melissa C; Schmidt, Jens; Kushlaf, Hani; Schiopu, Elena; Stipancic, Kaila; Goyal, Neelam; d'Alessandro, Miriana; Conticini, Edoardo; Cruz-Coble, Betsaida; Lloyd, Thomas E 2023. Current status of clinical outcome measures in inclusion body myositis: a systematised review. Clinical and experimental rheumatology, 41 2, 370-378

Roy, Bhaskar; Peck, Allison; Evangelista, Teresinha; Pfeffer, Gerald; Wang, Leo; Diaz-Manera, Jordi; Korb, Manisha; Wicklund, Matthew P; Milone, Margherita; Freimer, Miriam; Kushlaf, Hani; Villar-Quiles, Rocio-Nur; Stojkovic, Tanya; Needham, Merrilee; Palmio, Johanna; Lloyd, Thomas E; Keung, Benison; Mozaffar, Tahseen; Weihl, Conrad Chris; Kimonis, Virginia 2023. Provisional practice recommendation for the management of myopathy in VCP-associated multisystem proteinopathy. Annals of clinical and translational neurology, 10 5, 686-695

Hafeez, Komal; Kushlaf, Hani; Al-Sultani, Husam; Joseph, Anny-Claude; Zaeem, Zoya; Siddiqi, Zaeem; Laboy, Shannon; Pulley, Michael; Habib, Ali A; Robbins, Nathaniel M; Zadeh, Sean; Hafeez, Muhammad Ubaid; Hussain, Yessar; Melendez-Zaidi, Alexandria; Kassardjian, Charles; Johnson, Kristin; Leonhard, Holly; Biliciler, Suur; Patino Murillas, Jorge E; Shaibani, Aziz I 2022. Patient preference for virtual versus in-person visits in neuromuscular clinical practice. Muscle & nerve, ,

Korb, Manisha; Peck, Allison; Alfano, Lindsay N; Berger, Kenneth I; James, Meredith K; Ghoshal, Nupur; Healzer, Elise; Henchcliffe, Claire; Khan, Shaida; Mammen, Pradeep P A; Patel, Sujata; Pfeffer, Gerald; Ralston, Stuart H; Roy, Bhaskar; Seeley, William W; Swenson, Andrea; Mozaffar, Tahseen; Weihl, Conrad; Kimonis, Virginia 2022. Development of a standard of care for patients with valosin-containing protein associated multisystem proteinopathy. Orphanet journal of rare diseases, 17 1, 23

Kushlaf, Hani 2022. The applicability of the myasthenia gravis patient registry data to disease burden and medication changes in clinical practice. Muscle & nerve, ,

Schiava, Marianela; Ikenaga, Chiseko; Villar-Quiles, Rocío Nur; Caballero-Ávila, Marta; Topf, Ana; Nishino, Ichizo; Kimonis, Virginia; Udd, Bjarne; Schoser, Benedikt; Zanoteli, Edmar; Souza, Paulo Victor Sgobbi; Tasca, Giorgio; Lloyd, Thomas; Lopez-de Munain, Adolfo; Paradas, Carmen; Pegoraro, Elena; Nadaj-Pakleza, Aleksandra; De Bleecker, Jan; Badrising, Umesh; Alonso-Jiménez, Alicia; Kostera-Pruszczyk, Anna; Miralles, Francesc; Shin, Jin-Hong; Bevilacqua, Jorge Alfredo; Olivé, Montse; Vorgerd, Matthias; Kley, Rudi; Brady, Stefen; Williams, Timothy; Domínguez-González, Cristina; Papadimas, George K; Warman, Jodi; Claeys, Kristl G; de Visser, Marianne; Muelas, Nuria; LaForet, Pascal; Malfatti, Edoardo; Alfano, Lindsay N; Nair, Sruthi S; Manousakis, Georgios; Kushlaf, Hani A; Harms, Matthew B; Nance, Christopher; Ramos-Fransi, Alba; Rodolico, Carmelo; Hewamadduma, Channa; Cetin, Hakan; García-García, Jorge; Pál, Endre; Farrugia, Maria Elena; Lamont, Phillipa J; Quinn, Colin; Nedkova-Hristova, Velina; Peric, Stojan; Luo, Sushan; Oldfors, Anders; Taylor, Kate; Ralston, Stuart; Stojkovic, Tanya; Weihl, Conrad; Diaz-Manera, Jordi 2022. Genotype-phenotype correlations in valosin-containing protein disease: a retrospective muticentre study. Journal of neurology, neurosurgery, and psychiatry, ,

Bazrafshan, Sholeh; Kushlaf, Hani; Kakroo, Mashhood; Quinlan, John; Becker, Richard C; Sadayappan, Sakthivel 2021. Genetic Modifiers of Hereditary Neuromuscular Disorders and Cardiomyopathy. Cells, 10 2,

Diaz-Manera, Jordi; Kishnani, Priya S; Kushlaf, Hani; Ladha, Shafeeq; Mozaffar, Tahseen; Straub, Volker; Toscano, Antonio; van der Ploeg, Ans T; Berger, Kenneth I; Clemens, Paula R; Chien, Yin-Hsiu; Day, John W; Illarioshkin, Sergey; Roberts, Mark; Attarian, Shahram; Borges, Joao Lindolfo; Bouhour, Francoise; Choi, Young Chul; Erdem-Ozdamar, Sevim; Goker-Alpan, Ozlem; Kostera-Pruszczyk, Anna; Haack, Kristina An; Hug, Christopher; Huynh-Ba, Olivier; Johnson, Judith; Thibault, Nathan; Zhou, Tianyue; Dimachkie, Mazen M; Schoser, Benedikt 2021. Safety and efficacy of avalglucosidase alfa versus alglucosidase alfa in patients with late-onset Pompe disease (COMET): a phase 3, randomised, multicentre trial. The Lancet. Neurology, 20 12, 1012-1026

Kushlaf, Hani 2021. Immune Profiling Beyond Antibodies in Double Seronegative and Acetylcholine Receptor Antibody Positive Myasthenia Gravis: What do we Learn? Muscle & nerve, ,

Kushlaf, Hani; Ezzat, Kariem 2021. Extracellular amyloid deposition in sporadic inclusion body myositis: Further insights. Muscle & nerve, 64 5, 517-519

Kushlaf, Hani; Li, Yuebing 2021. How does rituximab fit in the treatment algorithm of myasthenia gravis? Muscle & nerve, 64 6, 635-636

Sandrone, Stefano; Albert, Dara Vf; Dunham, S Richard; Kraker, Jessica; Noviawaty, Ika; Palm, Michael; Kushlaf, Hani 2021. Training in Neurology: How Lessons Learned on Teaching, Well-being and Telemedicine During the COVID-19 Pandemic Can Shape the Future of Neurology Education. Neurology, ,

Schoser, Benedikt; Roberts, Mark; Byrne, Barry J; Sitaraman, Sheela; Jiang, Hai; Laforêt, Pascal; Toscano, Antonio; Castelli, Jeff; Díaz-Manera, Jordi; Goldman, Mitchell; van der Ploeg, Ans T; Bratkovic, Drago; Kuchipudi, Srilakshmi; Mozaffar, Tahseen; Kishnani, Priya S 2021. Safety and efficacy of cipaglucosidase alfa plus miglustat versus alglucosidase alfa plus placebo in late-onset Pompe disease (PROPEL): an international, randomised, double-blind, parallel-group, phase 3 trial. The Lancet. Neurology, 20 12, 1027-1037

Barohn, Richard J; Gajewski, Byron; Pasnoor, Mamatha; Brown, Alexandra; Herbelin, Laura L; Kimminau, Kim S; Mudaranthakam, Dinesh Pal; Jawdat, Omar; Dimachkie, Mazen M ; Iyadurai, Stanley; Stino, Amro; Kissel, John; Pascuzzi, Robert; Brannagan, Thomas; Wicklund, Matthew; Ahmed, Aiesha; Walk, David; Smith, Gordon; Quan, Dianna; Heitzman, Darryl; Tobon, Alejandro; Ladha, Shafeeq; Wolfe, Gil; Pulley, Michael; Hayat, Ghazala; Li, Yuebing; Thaisetthawatkul, Pariwat; Lewis, Richard; Biliciler, Suur; Sharma, Khema; Salajegheh, Kian; Trivedi, Jaya; Mallonee, William; Burns, Ted; Jacoby, Mark; Bril, Vera; Vu, Tuan; Ramchandren, Sindhu; Bazant, Mark; Austin, Sara; Karam, Chafic; Hussain, Yessar; Kutz, Christen; Twydell, Paul; Scelsa, Stephen; Kushlaf, Hani; Wymer, James; Hehir, Michael; Kolb, Noah; Ralph, Jeffrey; Barboi, Alexandru; Verma, Navin; Ahmed, Moiz; Memon, Anza; Saperstein, David; Lou, Jau-Shin; Swenson, Andrea; Cash, Tiyonnoh 2020. Patient Assisted Intervention for Neuropathy: Comparison of Treatment in Real Life Situations (PAIN-CONTRoLS): Bayesian Adaptive Comparative Effectiveness Randomized Trial. JAMA neurology, ,

Janecek, Jacqueline; Kushlaf, Hani 2020. Toxin-Induced Channelopathies, Neuromuscular Junction Disorders, and Myopathy. Neurologic clinics, 38 4, 765-780

Kushlaf, Hani 2020. DIVING INTO THE HETEROGENEITY OF INCLUSION BODY MYOSITIS. Muscle & nerve, ,

Kushlaf, Hani 2020. COVID-19 in muscle-specific kinase myasthenia gravis: A case report. Muscle & nerve, ,

Kushlaf, Hani 2020. Cystinosis myopathy: Searching for optimal clinical outcome measures. Muscle & nerve, ,

Kushlaf, Hani 2019. Peripheral Neuropathy and the Ceruloplasmin Gene. Annals of internal medicine, 170 4, 282

Kushlaf, Hani; Li, Yuebing 2019. The evidence is stacked against thymectomy in MuSK myasthenia gravis. Muscle & nerve, ,

Sandrone, Stefano; Berthaud, Jimmy V; Chuquilin, Miguel; Cios, Jacquelyne; Ghosh, Pritha; Gottlieb-Smith, Rachel J; Kushlaf, Hani; Mantri, Sneha; Masangkay, Neil; Menkes, Daniel L; Nevel, Kathryn S; Sarva, Harini; Schneider, Logan D 2019. Neurologic and neuroscience education: Mitigating neurophobia to mentor health care providers. Neurology, 92 4, 174-179

Davalos, Long; Kushlaf, Hani 2018. New onset of seropositive generalized myasthenia gravis following intravesical Bacille Calmette-Guerin treatment for bladder cancer: A case study. Muscle & nerve, ,

Lee, Ikjae; Kushlaf, Hani 2018. Needle electromyography practice patterns in patients taking novel oral anticoagulants: A survey-based study. Muscle & nerve, ,

Kushlaf, Hani A; Massey, E Wayne; Hobson-Webb, Lisa 2014. Proximal Median Neuropathy caused by Surgical Manipulation of Masson Tumor. Muscle & nerve, ,

Erra, Carmen; Granata, Giuseppe; Liotta, Giovanna; Podnar, Simon; Giannini, Mauro; Kushlaf, Hani; Hobson-Webb, Lisa D; Leversedge, Fraser J; Martinoli, Carlo; Padua, Luca 2013. Ultrasound diagnosis of bony nerve entrapment: case series and literature review. Muscle & nerve, 48 3, 445-50

Kushlaf, Hani A 2013. Emerging toxic neuropathies and myopathies. The Psychiatric clinics of North America, 36 2, 209-18

Kushlaf, Hani A 2011. Emerging toxic neuropathies and myopathies. Neurologic clinics, 29 3, 679-87

Kushlaf H. 12-01-2009. Toxic myopathies Clinical Neurotoxicology: Syndromes, Substances, Environments, , 159-173

Kushlaf H. 08-01-2021. Update on the Diagnostic and Therapeutic Landscape of Sporadic Inclusion Body Myositis Current Treatment Options in Neurology, 23 8,

Kushlaf H.A. 06-18-2009. Toxic Myopathies Clinical Neurotoxicology: Syndromes, Substances, Environments, Expert Consult - Online and Print, , 159-173

Hani Kushlaf, Vern Juel, Lisa Hobson-Webb 10-2012. Sonographically-measured nerve size and intra-nerve size variability in inflammatory polyneueropathy Muscle&Nerve and Clinical Neurophysiology, ,

Hani Kushlaf, Vern Juel, Lisa Hobson-Webb 10-2012. Do ultrasound characteristics correlate with electrodiagnostic findings in inflammatory neuropathies? Muscle&Nerve and Clinical Neurophysiology, ,

David Clark, Hani Kushlaf 10-16-2013. Macroglossia in Duchenne Muscular Dystrophy Muscle&Nerve and Clinical Neurophysiology, ,

Julia Zhu, Hani Kushlaf 03-16-2014. Camptocormia as the Initial Prominent Manifestation of Myotonic Dystrophy Type I , ,

Jonas Vanags, Hani Kushlaf, Vern Juel 02-2012. Post-irradiation hypoglossal and accessory neuropathies with myokymic discharges North Carolina Neurological society annual meeting, ,